Poolbeg Pharma (LSE:POLB) EBITDA Margin % : 0.00% (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Poolbeg Pharma EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Poolbeg Pharma's EBITDA for the six months ended in Jun. 2024 was £-2.52 Mil. Poolbeg Pharma's Revenue for the six months ended in Jun. 2024 was £0.00 Mil. Therefore, Poolbeg Pharma's EBITDA margin for the quarter that ended in Jun. 2024 was 0.00%.

Poolbeg Pharma EBITDA Margin % Historical Data

The historical data trend for Poolbeg Pharma's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poolbeg Pharma EBITDA Margin % Chart

Poolbeg Pharma Annual Data

Trend

Dec21

Dec22

Dec23

EBITDA Margin %

Poolbeg Pharma Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBITDA Margin %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Poolbeg Pharma's EBITDA Margin %

For the Biotechnology subindustry, Poolbeg Pharma's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Poolbeg Pharma's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poolbeg Pharma's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Poolbeg Pharma's EBITDA Margin % falls into.

Save Embed

;

Save Embed

;

Poolbeg Pharma EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Poolbeg Pharma's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-4.66	/	0
	=	%

Poolbeg Pharma's EBITDA Margin % for the quarter that ended in Jun. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	-2.516	/	0
	=	%

Poolbeg Pharma (LSE:POLB) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Poolbeg Pharma EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Poolbeg Pharma's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Poolbeg Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poolbeg Pharma PLC (LSE:POLB) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

7JN:Germany

Address

42 New Road, Queen Mary BioEnterprises Innovation Centre, London, GBR, E1 2AX

Website

https://www.poolbegpharma.com

Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.

Poolbeg Pharma Headlines

No Headlines